Skip to main content
. 2018 Feb 7;13(2):e0192157. doi: 10.1371/journal.pone.0192157

Table 2. Correlations between marker expressions and clinicopathological variables with stromal PDGFRα, PDGFRβ, αSMA and vimentin (chi-square and Fisher's exact tests).

PDGFRα S PDGFRβ S αSMA Vimentin
Low High P Low High P Low High P Low High P
Age 0.431 0.443 0.341 0.594
    <65 146 68 124 90 148 79 100 35
    ≥65 207 81 176 109 214 94 133 55
Gender 0.225 1.000 0.138 0.331
    Female 109 55 97 64 123 47 51 25
    Male 244 94 203 135 239 126 182 65
Weight-loss 0.659 0.119 0.602 0.808
    <10% 319 132 275 173 327 153 211 80
    >10% 34 17 25 26 35 20 22 10
Smoking status 0.842 0.100 0.726 0.041
    Never 10 4 12 2 10 7 13 0
    Present 222 98 184 132 233 109 146 63
    Previous 121 47 104 65 119 57 74 27
ECOG 0.756 0.003 0.704 0.860
    Normal 203 91 193 98 211 98 136 51
    Slightly 125 48 91 82 125 65 85 33
    In bed<50% 25 10 16 19 26 10 12 6
Histology 0.069 0.093 0.393 0.303
    SCC 190 83 152 120 198 90 137 53
    ADC 127 60 124 64 137 64 77 25
    NOS 36 6 24 15 27 19 19 12
T-stage 0.159 0.840 0.505 0.888
    T1a 49 22 45 26 53 21 25 11
    T1b 68 20 54 34 63 31 42 15
    T2a 127 49 101 71 128 61 86 36
    T2b 42 29 46 25 48 27 33 14
    T3 64 26 51 40 68 29 47 14
    T4 3 3 3 3 2 4 0 0
N-stage 0.273 0.911 0.541 0.227
    N0 237 105 202 136 248 116 159 64
    N1 85 27 68 42 75 42 58 16
    N2 31 17 30 21 39 15 16 10
P-stage 0.769 0.938 0.875 0.954
    IA 93 34 79 47 94 40 53 21
    IB 79 33 67 43 81 41 52 23
    IIA 82 32 65 45 76 42 63 21
    IIB 48 23 43 29 51 24 35 14
    IIIA 51 27 46 35 60 26 30 11
Differentiation 0.129 0.250 0.688 0.917
    Poor 153 59 131 78 160 70 98 39
    Moderate 152 77 138 91 158 82 104 38
    Well 48 13 31 30 44 21 31 13
Vascular invasion 0.520 0.906 0.012 0.236
    No 292 119 244 163 306 130 200 72
    Yes 60 29 55 35 55 42 33 18

Abbreviations: PDGFR, platelet derived growth factor; αSMA, alpha-smooth muscle actin; S, stroma; ECOG, Eastern cooperative oncology group; SCC, squamous cell carcinoma; ADC, adenocarcinoma; NOS, not otherwise specified